Phase II study of the efficacy and safety of intravenous (IV) AVE0005 (VEGF Trap) given every 2 weeks in patients (Pts) with platinum- and erlotinib- resistant adenocarcinoma of the lung (NSCLA) Meeting Abstract
| Authors: | Massarelli, E.; Miller, V. A.; Leighl, N. B.; Rosen, P. J.; Albain, K. S.; Hart, L. L.; Melnyk, O.; Sternas, L.; Ackerman, J.; Herbst, R. S. |
| Abstract Title: | Phase II study of the efficacy and safety of intravenous (IV) AVE0005 (VEGF Trap) given every 2 weeks in patients (Pts) with platinum- and erlotinib- resistant adenocarcinoma of the lung (NSCLA) |
| Meeting Title: | 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 25 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2007 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2007-06-20 |
| Start Page: | 416s |
| Language: | English |
| ACCESSION: | WOS:000455043702023 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2007.25.18_suppl.7627 |
| Notes: | Meeting Abstract: 7627 -- Source: Wos |
